Drug/Device Combo Gets Breakthrough Tx Status for Periprosthetic Joint Infection
The FDA has granted Breakthrough Therapy designation to VT-X7 for the treatment of periprosthetic joint infection of the hip and knee.
Source: empr.com
Page 43 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breakthrough Therapy Today - Breaking & Trending Today
89bio Reaches Alignment with the FDA and EMA on Phase 3 Program for Pegozafermin in Nonalcoholic Steatohepatitis (NASH); Program Initiation Planned in the First Half of 2024
—Alignment reached on key elements of the NASH development strategy, including accelerated approval pathway for both F4 and F2-F3 NASH patients using histology— —Outcomes trial in F4...
Source: marketscreener.com
FDA Offers Priority Review to Enfortumab Vedotin-Ejfv, Pembrolizumab Combination for Metastatic Bladder Cancer
If approved, this combination will become a first-line treatment option for patients who are cisplatin eligible.
Source: pharmacytimes.com
Savannah pastor faces multiple drug possession charges: MDMA, marijuana, mushrooms
A Savannah pastor was arrested Tuesday afternoon on multiple drug possession and distribution charges.According to a Tybee Island arrest report, 50-year-old Ge
Source: abcnews4.com
Theralase focused on breakthrough designation after positive preliminary study data
Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) is aiming to leverage positive study data during 3Q into a Breakthrough Therapy designation from the US...
Source: proactiveinvestors.com